HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress.

AbstractBACKGROUND:
Because hyperglycemia-induced oxidative stress may be a cause of retinopathy, this study examined the hypothesis that administration of exogenous antioxidants, stobadine (ST) and vitamin E (vitE), can restore retinal abnormalities in experimental diabetes.
METHODS:
Normal and streptozotocin (STZ)-induced male Wistar rats received daily intraoral doses of ST (24.7 mg/kg) and vitE (alpha-dl-tocopherol acetate, 400-500 IU/kg) individually or in combinations for 8 months. The biochemical parameters including aldose reductase enzyme (AR) activity and lipid peroxidation (MDA), and histopathological changes such as retinal capillary basement membrane thickness (RCBMT) and vascular endothelial growth factor (VEGF) expression were evaluated.
RESULTS:
A 37.99% increase in RCBMT was observed in rats after 8 months diabetes duration. The increase in RCBMT was 12.34% in diabetic rats treated with ST and 23.07% in diabetic rats treated with vitE. In diabetic rats treated with antioxidant combination, just a 4.38% increase was observed in RCBMT. The excess VEGF immunoreactivity and increased MDA and AR activity determined in diabetic retina were significantly attenuated by individual antioxidant treatments. Although both antioxidants decreased blood glucose, HbA1c, fructosamine and triglyceride levels in diabetic rats, poor glycemic control was maintained in all experimental groups during the treatment period. However, the antioxidant combination led to almost complete amelioration in retinal MDA and RCBMT in diabetic rats.
CONCLUSIONS:
The ability of antioxidant combination to arrest retinal abnormalities and lipid peroxidation even in the presence of poor glycemic control might advocate the key role of direct oxidative damage and the protective action of antioxidants in retinal alterations associated with diabetic retinopathy.
AuthorsFatma Yülek, Meral Or, Candan Ozoğul, Asli Ceylan Isik, Nuray Ari, Milan Stefek, Victor Bauer, Cimen Karasu
JournalArchives of medical research (Arch Med Res) Vol. 38 Issue 5 Pg. 503-11 (Jul 2007) ISSN: 0188-4409 [Print] United States
PMID17560455 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Blood Glucose
  • Carbolines
  • Endothelial Growth Factors
  • Vitamin E
  • Malondialdehyde
  • Aldehyde Reductase
  • dicarbine
Topics
  • Aldehyde Reductase (metabolism)
  • Animals
  • Antioxidants (pharmacology, therapeutic use)
  • Blood Glucose
  • Carbolines (administration & dosage, pharmacology, therapeutic use)
  • Diabetes Mellitus, Experimental (drug therapy, metabolism)
  • Diabetic Retinopathy (blood, drug therapy, metabolism)
  • Endothelial Growth Factors (metabolism)
  • Immunohistochemistry
  • Male
  • Malondialdehyde (metabolism)
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Retina (chemistry, enzymology, pathology)
  • Vitamin E (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: